🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 25 of 78

  1. US 10105409

    Therapeutic use of chardonnay seed products

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10105448

    Combined enteropathogen recombinant construct

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10106620

    Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cells

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10105434

    Immune enhancing recombinant dengue protein

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10100346

    Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10100020

    Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10098945

    Genetically engineered swine influenza virus and uses thereof

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10094836

    SLCO1B3 genotype

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10092637

    Dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10093641

    Process for making beraprost

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10093710

    Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10087211

    Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10087230

    Murine anti-NY-ESO-1 T cell receptors

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10087148

    Quinazolines as biogenic amine transport modulators

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10086061

    Combination purified inactivated vaccine for flaviviruses

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10081669

    Therapy for filovirus infection

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10080730

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10081658

    Truncated HIV envelope proteins (ENV), methods and compositions related thereto

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10081659

    Adeno-associated vectors for enhanced transduction and reduced immunogenicity

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10077296

    Methods and compositions for the treatment and prevention of cancer

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10076535

    Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10077250

    Antifungal compound process

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10077446

    Glucan-encapsulated siRNA for treating type 2 diabetes mellitus

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10076505

    Inhalation formulations of Treprostinil

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10072084

    Dual specific immunotoxin for brain tumor therapy

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10072070

    Potent anti-influenza A neuraminidase subtype N1 antibody

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10071945

    Nuclear receptor modulators and their use for the treatment and prevention of cancer

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10072078

    M971 chimeric antigen receptors

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10071123

    Treatment of pulmonary arterial hypertension with mesenchymal stem cells

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10064933

    Recombinant rift valley fever (RVF) viruses and methods of use

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10064858

    Methods and compositions for treating bacterial infections with iron chelators

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10058602

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10058559

    Treatment or prevention of an intestinal disease or disorder

    Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10053514

    Human bispecific EGFRvIII and CD3 antibody engaging molecules

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10052382

    Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10052374

    Compositions, methods and uses for dengue virus serotype-4 constructs

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10052369

    Aquaporin 2 protects cattle from ticks and tick-borne parasites

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10052362

    Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10051880

    Hydroxybutyrate ester and medical use thereof

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10053503

    Monoclonal antibodies that neutralize anthrax toxins

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10046012

    Multipotent postnatal stem cells from human periodontal ligament and uses thereof

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10047147

    Neutralizing GP41 antibodies and their use

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10047401

    Expression protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10047148

    Neutralizing GP41 antibodies and their use

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10047122

    Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10046024

    Cyclic-GluR6 analogs, methods of treatment and use

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10040830

    Methods and compositions for protein delivery

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10040826

    Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.